Mar 14
|
UPDATE 2-AstraZeneca to buy Amolyt Pharma for $1.05 bln to boost rare-disease portfolio
|
Mar 14
|
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare-disease portfolio
|
Mar 13
|
Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts
|
Mar 13
|
AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD
|
Mar 11
|
Reasons for the Decline of AstraZeneca PLC (AZN) in Q4
|
Mar 7
|
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
|
Mar 7
|
UPDATE 2-Astra-Sanofi's RSV therapy 90% effective against infant hospitalizations, CDC study shows
|
Mar 7
|
Compugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call Transcript
|
Mar 7
|
Biden Will Tout Lower Drug Prices in State of the Union. Why Big Pharma Might Be Losing the Fight.
|
Mar 7
|
PRESS DIGEST-British Business - March 7
|
Mar 6
|
AstraZeneca Announed Further GBP200 Million Investment Announced to Expand Presence in Cambridge
|
Mar 6
|
AstraZeneca to build £450m vaccine hub in Liverpool in boost for UK
|
Mar 6
|
AstraZeneca to invest 650 million pounds in UK to boost 'pandemic preparedness'
|
Mar 6
|
Column: A Trump judge slaps down Big Pharma's attack on Biden's drug price cuts
|
Mar 6
|
Q4 2023 Sophia Genetics SA Earnings Call
|
Mar 5
|
15 Countries with the Highest Prostate Cancer Rates in the World
|
Mar 4
|
AstraZeneca’s drug pricing lawsuit dismissed by federal judge
|
Jan 16
|
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
Jan 16
|
4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn’t One.
|
Jan 16
|
Trending tickers: Apple | Tesla | AstraZeneca | Hugo Boss
|